IBM International Business Machines Corporation

IBM Announces Senior Roles for “NewCo,” the Independent Managed Infrastructure Services Business to Spin Out from IBM

IBM (NYSE:IBM) today announced key members of the executive team to lead the independent company that will be created following the previously announced separation of IBM’s Managed Infrastructure Services business (“NewCo”).

This press release features multimedia. View the full release here:

Elly Keinan Group President NewCo (Photo: Business Wire)

Elly Keinan Group President NewCo (Photo: Business Wire)

The leadership appointments represent an important step toward establishing an independent NewCo, which will be a global leader in the management and modernization of IT infrastructure. The company’s new name will be announced in the coming months, and the separation is expected to occur by the end of 2021.

Elly Keinan was named as Group President of the new company. Maria Bartolome Winans has been named as NewCo’s Chief Marketing Officer. Both executives are veterans of the technology industry and have held global leadership roles.

“These executives bring great global expertise as we build a purpose-led culture for our new company,” said Martin Schroeter, who assumed the role of NewCo’s Chief Executive Officer on January 15. “Elly and Maria have deep knowledge of the industry, and they share our unwavering commitment to our talented employees and to the success of our customers. I know they will play a pivotal role in the leadership team we are building to deliver excellent value to customers and shareholders.”

Keinan is a veteran of more than three decades in the technology industry, most recently as a venture partner of Pitango Venture Capital, Israel’s leading venture capital group. He served as general manager of IBM North America, general manager of IBM Latin America, and chairman of IBM Japan, among many technology and market leadership roles at IBM. He serves on boards of several technology companies, as well as the board of directors of the United Way of New York City.

Winans has risen to top marketing roles in her 25-year career at IBM and has spent the last three years as the chief marketing officer for IBM Americas, with direct responsibility for marketing sourced revenue, demand generation and all geography marketing professionals across North America, Canada, and Latin America. She has led marketing teams in IBM’s Watson business and in IBM’s Software unit, with specific expertise in industry solutions, and has been a leader in IBM’s Hispanic community.

NewCo will be a leading technology services provider, with twice the scale of its nearest competitor in managed infrastructure services. It has relationships with more than 4,600 technology-intensive, highly regulated customers and a backlog of more than $60 billion. Managing and modernizing customer-owned infrastructures is a $500 billion market opportunity.

EN
03/03/2021

Underlying

Reports on International Business Machines Corporation

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
HURN HURON CONSULTING GROUP INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BZH BEAZER HOMES USA INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
INOD INNODATA
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
CVCO CAVCO INDUSTRIES INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
ATXS ASTRIA THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch